Page last updated: 2024-12-04

15-hydroxy-5,8,11,13,17-eicosapentaenoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 15-Hydroxy-5,8,11,13,17-Eicosapentaenoic Acid (15-HEPE)

**15-HEPE** is a **hydroxy-eicosapentaenoic acid (HEPE)**, a type of **omega-3 fatty acid** that is a product of the **oxygenation of eicosapentaenoic acid (EPA)**. This oxygenation is catalyzed by **15-lipoxygenase (15-LOX)**, an enzyme found in various cells, including platelets, leukocytes, and endothelial cells.

**Importance for Research:**

15-HEPE is gaining increasing interest in research due to its potential roles in a variety of physiological processes and disease states. These include:

**1. Inflammation and Immune Response:**

* **Anti-inflammatory effects:** Studies suggest 15-HEPE has anti-inflammatory properties, potentially acting as a counter-regulator to pro-inflammatory mediators. This may be relevant in conditions like inflammatory bowel disease, arthritis, and asthma.
* **Modulation of immune cells:** 15-HEPE can influence the function of immune cells like macrophages and T cells, contributing to the resolution of inflammation and immune homeostasis.

**2. Cardiovascular Health:**

* **Blood pressure regulation:** 15-HEPE may play a role in regulating blood pressure by influencing vascular tone and reducing platelet aggregation.
* **Cardioprotective effects:** Studies have linked 15-HEPE with cardioprotective effects, potentially by reducing oxidative stress and inflammation within the heart.

**3. Neurological Function:**

* **Neuroprotection:** Research indicates that 15-HEPE could offer neuroprotective benefits against neurodegenerative diseases like Alzheimer's and Parkinson's disease.
* **Anti-depressant effects:** Some studies suggest a potential role for 15-HEPE in mitigating depression symptoms, although more research is needed.

**4. Cancer:**

* **Anticancer properties:** 15-HEPE has shown promise in pre-clinical studies as an anticancer agent, particularly against colon, breast, and lung cancers. This may be due to its ability to induce apoptosis (programmed cell death) in cancer cells.

**5. Metabolism:**

* **Lipid metabolism:** 15-HEPE can modulate lipid metabolism, potentially impacting cholesterol levels and insulin sensitivity.

**Ongoing Research:**

While 15-HEPE shows promise in these areas, research is still ongoing to fully understand its mechanisms of action, therapeutic potential, and safety profile. More studies are needed to investigate its clinical implications in various diseases and conditions.

**In summary, 15-HEPE is a bioactive lipid derived from EPA with potential implications for inflammation, cardiovascular health, neurological function, cancer, and metabolism. Its increasing research interest highlights its promising therapeutic potential and importance in understanding complex biological processes.**

15-hydroxy-5,8,11,13,17-eicosapentaenoic acid: structure given in first source; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1435
MeSH IDM0164656

Synonyms (6)

Synonym
15-hydroxy-5,8,11,13,17-eicosapentaenoic acid
15-hydroxyicosa-5,8,11,13,17-pentaenoic acid
97850-14-1
FT-0642105
FT-0642037
DTXSID40904331

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Freshly excised full-thickness porcine skin in Franz diffusion cells was dosed (both infinite and finite) with simple formulations based on fish oil as source of EPA."( Probing the skin permeation of eicosapentaenoic acid and ketoprofen 2. Comparative depth profiling and metabolism of eicosapentaenoic acid.
Heard, CM; Thomas, CP, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.11)18.7374
1990's2 (11.11)18.2507
2000's4 (22.22)29.6817
2010's10 (55.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.03 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.56%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]